Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Nov 21, 2011
GEN interviews Roland Buelow, Ph.D., about his company, Open Monoclonal Technology (OMT), and its rat platform for antibody engineering. To hear more from Dr. Buelow, click here: http://www.genengnews.com/gen-article...